Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.66 USD | -0.18% | +5.40% | -44.13% |
May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
May. 01 | Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.13% | 465M | |
+22.81% | 46.81B | |
+47.13% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Editas Medicine : Q2 Loss Widens, Revenue Declines